#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucous membrane pemphigoid Leiomyosarcoma metastatic Systemic lupus erythematosus Focal segmental glomerulosclerosis Hyperinsulinism Mitochondrial myopathy Synovial sarcoma metastatic High-grade B-cell lymphoma Chronic graft versus host disease in liver Cryoglobulinaemia Acute myeloid leukaemia Non-small cell lung cancer Hidradenitis Heritable pulmonary arterial hypertension Cardiac sarcoidosis More trials…

    Learn about Rare Diseases

    Vascular malformation – Life with Disease Glycogen storage disease type I Ewing’s sarcoma Netherton’s syndrome – Diagnostics Systemic mastocytosis Isodicentric chromosome 15 syndrome – Trials in Disease Congenital generalised lipodystrophy – Life with Disease Anaplastic thyroid cancer – Trials in Disease Osteosarcoma metastatic – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Granisetron Bendamustine Hydrochloride Nivolumab Collagenase Acp-017 Pelareorep Tapderimotide Zolbetuximab L-LEUCINE Quinidine Sulfate Stiripentol Magnesium Oxybate Gsk4004280 Epirubicin Gebasaxturev Iph5201 SGN-ALPV Betamethasone Dipropionate ZOLPIDEM TARTRATE Glipizide More therapies…

    Learn about Your Condition

    Food allergy Acute myeloid leukaemia Lichen sclerosus Postoperative wound infection Ovarian cancer stage IV Endometrial cancer stage III K-ras gene mutation Atrial fibrillation Burkitt's lymphoma Cardiac amyloidosis Biotinidase deficiency Apheresis Knee arthroplasty Phenylketonuria Post procedural hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors

    Recruiting

    2 1 1
    The Netherlands Spain

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +19

  • An observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Carbidopa
    • Levodopa
    Sweden

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Finland

  • A study to evaluate the use of diroximel fumarate to reduce brain swelling in patients with a stroke caused by bleeding in the brain.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Diroximel Fumarate
    France

  • A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vutrisiran
    Cyprus France Germany Greece Ireland Italy +3
Previous Page
1 … 3 4 5 6 7 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!